Patents by Inventor Nesya Goris

Nesya Goris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11904024
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Grant
    Filed: March 18, 2021
    Date of Patent: February 20, 2024
    Assignee: Aratana Therapeutics, Inc.
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Maryline Roe, Pascal Puig
  • Publication number: 20230183718
    Abstract: Provided herein are methods for the production of a vector with a size of at least 16 kb from bacterial cells comprising the consecutive steps of a) obtaining bacterial cells comprising a vector with a size of at least 16 kb, comprising an inducible origin of replication, b) inoculating culture medium with the bacterial cells comprising the vector, c) culturing the bacterial cells in the culture medium, d) adding one or more inducers of said inducible origin of replication to the culture medium when the bacterial culture has reached an optical density at 600 nm (OD600) of at least 20, e) further culturing the bacterial cells in the culture medium, f) optionally separating the bacterial cells from the culture medium, and g) recovering the plasmid from the bacterial cells. Also provided herein are vectors with a size of at least 16 kb comprising an inducible origin of replication for use in such methods.
    Type: Application
    Filed: September 25, 2020
    Publication date: June 15, 2023
    Applicant: Katholieke Universiteit Leuven
    Inventors: Melody Janssen, Joeri Auwerx, Kai Dallmeier, Nicolas Ongenae, Cédric Vansalen, Nesya Goris
  • Patent number: 10967074
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: April 6, 2021
    Assignee: ARATANA THERAPEUTICS, INC.
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Maryline Roe, Pascal Puig
  • Patent number: 9107943
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: August 18, 2015
    Assignee: ARATANA THERAPEUTICS NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Maryline Roe, Pascal Puig
  • Publication number: 20150098904
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Application
    Filed: January 20, 2012
    Publication date: April 9, 2015
    Applicant: ARATANA THERAPEUTICS NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Maryline Roe, Pascal Puig
  • Publication number: 20150018427
    Abstract: The present invention relates to compounds for use in a method for the treatment or prevention of parvovirus infections in humans and warm-blooded animals, including feline panleukopenia virus (FPV) infections in felids, canine parvovirus type 2 (CPV-2) infections in canines, minute virus of mice (MVM) infections in mice and B19 parvovirus infections in humans.
    Type: Application
    Filed: February 22, 2013
    Publication date: January 15, 2015
    Applicant: Aratana Therapeutics NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Jérôme Villers, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Eleonora Kiss, Chloë Swinnen
  • Publication number: 20140073607
    Abstract: The present invention relates to compounds and compositions for use in the treatment or prevention of retroviral infections in felines, in particular cats, and to the use of said derivatives for the manufacture of a medicament for the treatment or prevention of feline leukemia virus (FeLV) infections occurring alone or together with feline immunodeficiency virus (FIV) infections in cats.
    Type: Application
    Filed: May 10, 2011
    Publication date: March 13, 2014
    Applicant: OKAPI SCIENCES NV
    Inventors: Nina Justa, Katrin Hartmann, Sylvie Daminet, Mariella Debille, Joeri Auwerx, Nesya Goris, Stefaan Wera, Erwin Blomsma, Aino Billiet, Jan Swinnen, Bert Vrancx, Veerle Debeurme, Johan Neyts